Brief Overview of EGRIFTA SV® Reconstitution

Preparing EGRIFTA SV® for injection

The daily 1.4 mg dose of EGRIFTA SV® is reconstituted from a vial containing 2 mg of tesamorelin as a lyophilized powder

  • The total volume of reconstitution is 0.35 mL
  • Sterile Water for Injection, USP (10 mL) for reconstitution is provided in a separate bottle

Once reconstituted, EGRIFTA SV® should be administered immediately

Fill syringe with sterile water to 0.5 mL line

Inject sterile water into EGRIFTA SV® vial and roll vial gently in your hands for 30 seconds